Ducommun (DCO) Q1 2026 Earnings Transcript

Ducommun posted first-quarter revenue of $209 million, up 9% year over year, with gross margin expanding to 26.9% and adjusted EBITDA rising to $35.4 million, or 16.9% of revenue. Commercial aerospace revenue grew 18% and defense revenue rose 5%, while backlog reached about $1.1 billion and trailing 12-month book-to-bill was 1.1x overall. Management reiterated 2026 revenue growth guidance in the mid- to high-single digits and said margin improvement should continue as destocking eases and missile-related orders ramp later in 2026 into 2027.

Analysis

The key read-through is not the quarter itself, but the sequencing: DCO is using a still-benign commercial cycle to bridge into a defense step-up that should become visible in orders before it shows up in revenue. That creates a favorable setup for multiple expansion if management can demonstrate the missile framework agreements are converting into backlog by the second half, because the market will likely start discounting 2027 growth before the P&L catches up. The balance sheet improvement matters here too: lower financing friction increases optionality for tuck-in M&A just as the company’s engineered-product mix reaches a level that should mechanically support higher margins.

Second-order winners are the prime contractors and platform owners that need content-rich, incumbent suppliers with available capacity. The likely loser is any smaller Tier 2/3 supplier still constrained by labor or footprint, because DCO is explicitly signaling it can absorb ramp without capex-heavy expansion; that usually shifts share toward incumbents with the cleanest execution history. For Boeing and Airbus exposure, the near-term issue is less demand than destocking and rate timing, which means suppliers with heavy commercial mix may report choppy quarters even as underlying builds improve.

The main risk is that investors over-earnest about the missile thesis may be too early. If backlog conversion slips from late-2026 into 2027, the stock can stall despite strong narrative momentum, especially because the current quarter already benefited from mix, pricing, and consolidation savings that are harder to repeat. The contrarian angle is that consensus may be underestimating how much of 2026 is already being pulled forward into Q1; that can flatten sequential growth and set up a tactical reset before the defense acceleration becomes visible.

Net: this is a quality industrial-defense compounder with a visible 12-24 month re-rating path, but the best entry is likely on any post-earnings compression tied to destocking noise rather than on headline strength. The setup favors owning the name into September Investor Day if management can quantify out-year missile content and M&A priorities with enough specificity to validate the 2027-2032 bridge.

Key Decisions for Investors

• Initiate/add to long DCO on any 5-8% pullback over the next 2-6 weeks; target a 12-18 month move as missile backlog converts and margin expansion persists, with downside protected by improving liquidity and visible cash generation.
• Pair trade: long DCO / short SPR for the next 6-12 months. DCO has more operating leverage to defense ramp and less binary customer-concentration risk, while SPR remains more exposed to commercial-rate and integration noise.
• Buy DCO Jan-2027 call spreads on weakness. The catalyst window is late-2026 into 2027 when missile orders should start translating into backlog and then revenue; the spread captures upside while limiting premium burn during destocking noise.
• Short-term hedge: if already long industrials, trim BA-adjacent suppliers with heavier commercial content until destocking commentary clears. DCO is better positioned than many peers, but the sector could de-rate on any airline inventory surprise.
• Add RTX/LMT as a thematic hedge against delayed missile revenue recognition at DCO; if prime production ramps faster than expected, DCO should benefit, but the primes provide cleaner exposure to the same end-market reacceleration.